Indeed, liver and global deletion of ChREBP lead to glucose intolerance and insulin resistance in mice (8, 20), while liver-specific ChREBP overexpression in mice fed a high-fat diet ameliorates insulin signaling despite increased hepatic lipid accumulation (23). The gene discussed is MLXIPL; the disease is Glucose intolerance.